A direct-to-consumer program for its drugs could bring down higher U.S. drug prices while cutting out pharmacy benefit ...

Global pharmaceutical giants make billions of dollars in Australia but pay a fraction of that in tax. They say the price they ...

Pfizer And Drug Pricing: Should You Invest Now? May 15, 2025 — 01:55 am EDT. ... At its current price of $23, Pfizer stock trades at just 8 times trailing earnings of $2.91 per share.

The Swiss drugmaker discussed the option of selling drugs directly to patients with U.S. officials following Trump ...

In advance of CMS’ negotiated price for the blood thinner taking effect next year, partners Bristol Myers Squibb and Pfizer ...

There is bipartisan consensus that drugs in the U.S. cost a lot more than in other high-income countries; therefore, it is important to comprehend how governmental interventions in other nations can ...

Drugmakers will offer Eliquis at a 43% discount to uninsured U.S. patients, bypassing insurers and PBMs New $346 monthly ...

The companies’ new effort would bypass traditional middlemen to cut the drug’s monthly cost from a list price of around $606 ...

(Reuters) -Pfizer and other drug companies have met with the Trump administration to discuss lowering U.S. drug prices but no commitments have been made, Chief Executive Albert Bourla said on Monday.

No Drug Price Pledges by Pfizer, Others in Talks With US Government, Pfizer CEO Says. More. Reuters. FILE PHOTO: Pfizer logo is seen in this illustration taken, May 1, 2022.